Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular Risk.
Zhou XD, Chen QF, Kim SU, Yip TC, Petta S, Nakajima A, Tsochatzis E, Boursier J, Bugianesi E, Hagström H, Chan WK, Romero-Gomez M, Calleja JL, de Lédinghen V, Castéra L, Sanyal AJ, Goh BG, Newsome PN, Fan JG, Lai M, Fournier-Poizat C, Lee HW, Wong GL, Armandi A, Shang Y, Pennisi G, Llop E, Yoneda M, Zoncapè M, de Saint-Loup M, Gallego-Durán R, Carrillo-Fernández P, Asgharpour A, Teh KK, Chan MS, Lin H, Liu WY, Targher G, Byrne CD, Wong VW, Zheng MH.
Zhou XD, et al. Among authors: lin h.
Clin Gastroenterol Hepatol. 2026 Feb 6:S1542-3565(26)00067-4. doi: 10.1016/j.cgh.2026.01.038. Online ahead of print.
Clin Gastroenterol Hepatol. 2026.
PMID: 41655804